Latest Articles on Biosimilars
![scientists in laboratory scientists in laboratory](/sites/default/files/us/2022-07/banner.jpg)
Article
Boehringer Ingelheim Fremont, Inc.
Based in the San Francisco Bay Area, Boehringer Ingelheim’s only US Biopharmaceutical manufacturing site represents the company’s history as a biotechnology pioneer.
Read more
![Grey Vials](/sites/default/files/us/2023-04/what_are_biosimilars.jpg)
Article
Bringing Value to the Healthcare Community
Our fundamental mission is to make the lives of patients better. We listen, we take the time to understand, and through meaningful and impactful partnerships, we aim to create a lasting difference.
Read more
Press Releases
![Physician talking with patient Physician talking with patient](/sites/default/files/us/2023-07/Cyltezo-Launch-teaser.jpg)
July 01, 2023
Interchangeable biosimilar now available in the U.S.
![physician talking with patient physician talking with patient](/sites/default/files/us/2023-06/Cyltezo.jpg)
June 23, 2023
Optum Rx Places Interchangeable Biosimilar on its Commercial Formulary
Downloads
![Boehringer Ingelheim explains the basics of biosimilars and interchangeability. Boehringer Ingelheim explains the basics of biosimilars and interchangeability.](/sites/default/files/2024-03/Boehringer_HR_Lab_WorkDay.jpg)
Breaking Down Biosimilars Infographic
![biosimilar molecules biosimilar molecules](/sites/default/files/us/2022-06/shutterstock_240669547_small.jpg)
Potential Savings from Interchangeable Biosimilars in the Pharmacy Benefit
![molecule graphic molecule graphic](/sites/default/files/us/2022-06/shutterstock_1155322561_cmyk.png)